Pharmaniaga said the consistently high demand from government hospitals enabled it to boost its year-on-year revenue to RM1.8bil, a 4.5% jump from the RM1.7bil recorded in the corresponding nine months last year.
PETALING JAYA: Pharmaniaga Bhd
has earmarked RM174mil in capital expenditure this year for product innovation and new manufacturing plants for oncology and vaccine related products.
Managing director Datuk Farshila Emran said the medical group is planning to introduce 250 products in the next five years ranging from oncology and vaccine to phytomedicine.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
